Product
LPX-TI641
1 clinical trial
2 indications
Indication
Autoimmune DiseasesIndication
Multiple SclerosisClinical trial
A Phase I First in Human, Randomized, Double-blind, Placebo- Controlled Study in Healthy Adult Volunteers to Evaluate Safety, Tolerability and Pharmacokinetics of LPX-TI641 After Single Oral Doses.Status: Recruiting, Estimated PCD: 2024-04-15